Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B

by Hadziyannis, S.J., Tassopoulos, N.C., Heathcote, E.J., Chang, T.-T., Kitis, G., Rizzetto, M., Marcellin, P., Lim, S.G., Goodman, Z., Wulfsohn, M.S., Xiong, S., Fry, J., Brosgart, C.L.
Published 2014

Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years

by Hadziyannis, S.J., Tassopoulos, N.C., Heathcote, E.J., Chang, T., Kitis, G., Rizzetto, M., Marcellin, P., Lim, S.G., Goodman, Z., Ma, J., Brosgart, C.L., Borroto-Esoda, K., Arterburn, S., Chuck, S.L.
Published 2011

Treatment of hepatitis B e antigen-positive chronic hepatitis with telbivudine or adefovir: A randomized trial

by Chan, H.L.Y., Heathcote, E.J., Marcellin, P., Lai, C.-L., Cho, M., Moon, Y.M., Chao, Y.-C., Myers, R.P., Minuk, G.Y., Jeffers, L., Sievert, W., Bzowej, N., Harb, G., Kaiser, R., Qiao, X.-J., Brown, N.A., Crawford, D., Lim, S.-G., Chutaputti, A., Poynard, T.
Published 2016